Gilead and Arcus Announce Amended Collaboration and Equity Investment

– Investment Reinforces Companies’ Conviction in TIGIT Pathway and Provides Opportunity to Accelerate the Anti-TIGIT Program –


– Additional Equity Investment of $320M, Raising Gilead’s...

Related Keywords

Foster City ,California ,United States ,China ,Merdad Parsey ,Terry Rosen ,Johanna Mercier ,Arcus Biosciences Inc ,Guangzhou Gloria Biosciences Co ,Astrazeneca ,Gilead Sciences Inc ,Exchange Commission ,Nasdaq ,Gilead Sciences ,Arcus Biosciences ,Chief Commercial Officer ,Marcus Board ,Chief Medical Officer ,Chief Executive Officer ,Gloria Biosciences ,Arcus Bioscience ,Private Securities Litigation Reform Act ,Quarterly Report ,Markets ,